STAT5A and chronic myelogenous leukemia, BCR-ABL1 positive: HSP70 was also found to induce STAT5 expression and drug resistance in AML and CML cells and inhibition of STAT5 activity was sufficient to resensitize resistant leukemic cells to chemotherapy [34,38].